ZC3H7A/B::BCOR fusion fibromyxoid sarcoma of soft tissue: an emerging aggressive sarcoma overlapping with malignant ossifying fibromyxoid tumors

Rekhi B, Kavuncuoglu A, Din NU, Rastogi S, Abdelsatir A, Stöhr R, Agaimy A, Kosemehmetoglu K (2025)

Publication Type: Journal article

Publication year: 2025

Journal

Virchows Archiv Springer Verlag (Germany)

DOI: 10.1007/s00428-025-04177-4

Abstract

BCOR-rearranged sarcomas constitute ultra-rare tumors. Among these, ZC3H7A/B::BCOR sarcomas are less common and are primarily reported as a subset of high-grade endometrial stromal sarcomas, as well as in the spectrum of malignant ossifying fibromyxoid tumors (OFMTs). Herein, we present the clinicopathological, immunohistochemical, and molecular profiles of seven soft tissue tumors exhibiting ZC3H7A/B::BCOR fusions. The patient’s age ranged from 13 to 65 years (median = 38). Locations were neck (2) and one case each in the paraspinal region, scalp, gluteal region, chest wall, and thigh. Histologically, the tumors were composed of round to polygonal or spindle-shaped cells with a variable amount of fibromyxoid stroma, lacking bone shell or ossification, leading to a range of initial differential diagnoses. Immunohistochemically, the tumor cells were positive for S100 (5/6), cyclin D1 (2/3), SATB2 (2/3), BCOR (2/4), and TLE1 (1/3) while negative for MUC4 (0/6), keratin (0/5), EMA (0/4), desmin (0/6), CD34 (0/6), SMA (0/5), SOX10 (0/5), and melanoma cocktail (0/2). Targeted RNA sequencing revealed ZC3H7B::BCOR fusions in six tumors (four with ZC3H7Bex10::BCORex6 and one each ZC3H7Bex12::BCORex7 and ZC3H7Bex12::BCORex6). One tumor revealed a ZC3H7Aex10::BCORex6 fusion. All seven tumors were resected, mostly with clear margins (5/7), including two patients who received adjuvant therapy. Three of four patients with available follow-up (mean = 45 months) died of disease, while one patient was alive with multiple bone metastases. This series comprises seven additional ZC3H7A/B::BCOR soft tissue sarcomas associated with aggressive clinical outcomes. Whether this aggressive sarcoma represents a molecular subtype of malignant OFMT or a genetic variant of BCOR-rearranged sarcomas remains to be further verified.

Authors with CRIS profile

Robert Stöhr Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Abbas Agaimy Institute of Pathology

Involved external institutions

University of Miami US United States (USA) (US) Tata Memorial Hospital IN India (IN) All India Institute of Medical Sciences IN India (IN) Hacettepe University TR Turkey (TR)

How to cite

APA:

Rekhi, B., Kavuncuoglu, A., Din, N.U., Rastogi, S., Abdelsatir, A., Stöhr, R.,... Kosemehmetoglu, K. (2025). ZC3H7A/B::BCOR fusion fibromyxoid sarcoma of soft tissue: an emerging aggressive sarcoma overlapping with malignant ossifying fibromyxoid tumors. Virchows Archiv. https://doi.org/10.1007/s00428-025-04177-4

MLA:

Rekhi, Bharat, et al. "ZC3H7A/B::BCOR fusion fibromyxoid sarcoma of soft tissue: an emerging aggressive sarcoma overlapping with malignant ossifying fibromyxoid tumors." Virchows Archiv (2025).

BibTeX: Download